Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Oracle’s Global AI Push Fuels Stock Surge Amidst Costly Restructuring

SiterGedge by SiterGedge
April 23, 2026
in Dividends, Tech & Software, Trading & Momentum, Turnaround
0
Oracle Stock
0
SHARES
89
VIEWS
Share on FacebookShare on Twitter

Oracle shares climbed over 4% intraday on Thursday, a rally coinciding with the payment of a $0.50 per share quarterly dividend. This advance extends a remarkable recovery, with the stock up roughly 39% from its February 52-week low and gaining more than 26% over the past 30 days. The stock currently trades at 161.26 EUR, a daily increase of 2.71%, though it remains about 43% below its September 2025 all-time high of 280.70 EUR.

Driving this momentum is a massive, capital-intensive expansion of the company’s artificial intelligence infrastructure. Oracle recently announced a significant expansion of its partnership with Google Cloud, making its Oracle AI Database@Google Cloud service available in 15 global regions, including Frankfurt, London, Tokyo, Sydney, Mumbai, and Toronto. Plans are in place to add Turin and Mexico within the next twelve months. This technical rollout includes the general availability of OCI GoldenGate for real-time database migrations and integrations with Google BigQuery and BigLake, facilitating cross-platform data access.

This aggressive growth strategy comes with a hefty price tag and internal upheaval. For fiscal year 2026, Oracle has raised its planned capital expenditures to $50 billion, up from a previous forecast of $35 billion. Concurrently, the company is undergoing a major restructuring, with reports indicating approximately 12,000 job cuts in India and unconfirmed industry sources suggesting up to 30,000 positions affected globally. The associated restructuring costs are estimated to reach $2.1 billion.

Financially, the results show robust top-line growth burdened by significant investment. Third-quarter fiscal 2026 revenue reached $17.19 billion, a nearly 22% year-over-year increase, with Cloud Infrastructure (IaaS) revenue surging 68%. However, long-term debt stands at $124.7 billion, with interest expenses rising 32% to $1.18 billion. Free cash flow remains deeply negative, driven by $48.25 billion in investment spending over the past four quarters.

The bull case for Oracle hinges on its unprecedented backlog. The company’s remaining performance obligations hit a record $553 billion, including a $300 billion contract signed with OpenAI in late 2025 and other major deals with Meta and xAI. Management emphasizes that much of the required equipment is either funded by customer prepayments or provided directly by clients, aiming to limit Oracle’s own capital risk.

Should investors sell immediately? Or is it worth buying Oracle?

Analyst sentiment reflects the stock’s dichotomous narrative. According to MarketBeat, 40 brokerages cover the stock with a consensus “Moderate Buy” rating. Price targets range widely from $160 to $400. Analysts at CreditSights and Guggenheim have issued positive ratings, citing the strong order backlog, while others remain cautious about the capital intensity of the AI build-out.

Looking ahead, Oracle’s management expects fourth-quarter fiscal 2026 earnings per share between $1.96 and $2.00. The company’s long-term targets are ambitious: it aims for total revenue of $90 billion by 2027 and $225 billion by 2030. A key pillar is Cloud Infrastructure revenue, which Oracle projects will grow from $18 billion this fiscal year to $32 billion next year, with further leaps anticipated, supported by a projected annual growth rate of 31% in this segment.

Valuation debates are intense. A discounted cash flow model from Simply Wall St. calculates a fair value of approximately $266 per share, suggesting the current price trades at a discount of about one-third. The stock’s price-to-earnings ratio of around 31.6 is near the industry average of 30 but well below the peer-group average of 56. The 28.6 RSI reading indicates technically oversold conditions, which may partly explain the recent rebound.

A shadow over the investment thesis is the ongoing class-action lawsuit “Barrows v. Oracle,” which alleges the company misled investors about the feasibility of its AI investment strategy. This legal proceeding is set to continue influencing the valuation discussion.

Ultimately, Oracle’s ability to sustain its stock recovery depends on translating its massive capital expenditures and record backlog into sustained, positive free cash flow. The company is betting its future on becoming a foundational AI infrastructure player, a high-stakes strategy playing out across global data centers and balance sheets.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from October 22 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

Oracle: Buy or sell? Read more here...

Tags: Oracle
SiterGedge

SiterGedge

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
D-Wave Quantum Stock
AI & Quantum Computing

D-Wave Quantum: A Network Metric That Cuts Through the Noise

September 7, 2026
Next Post
Gerresheimer Stock

Gerresheimer's Creditors Grant Reprieve as Strategic Overhaul Intensifies

AMD Stock

AMD's Record Rally Fueled by Niche CPU Launch and Surging AI Demand

Airbus Stock

Airbus Charts Dual Course with Cyber Acquisitions and A350F Milestone

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com